[{"Assets_0_Q3_USD":"11895471000.0","CIK":"1593034","CommonStockSharesIssued_0_Q3_shares":"223301809.0","CommonStockSharesOutstanding_0_Q3_shares":"223301809.0","Country":"Ireland","EarningsPerShareBasic_1_Q3_USD":"-0.43","EarningsPerShareBasic_3_Q3_USD":"-7.47","EarningsPerShareDiluted_1_Q3_USD":"-0.43","EarningsPerShareDiluted_3_Q3_USD":"-7.47","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"424062000.0","NetIncomeLoss_1_Q3_USD":"-96670000.0","NetIncomeLoss_3_Q3_USD":"-1667016000.0","OfficialName":"Endo International plc Ordinary Shares","ProfitLoss_1_Q3_USD":"-96670000.0","ProfitLoss_3_Q3_USD":"-1667016000.0","RevenuesConverted_1_Q3_USD":"786887000.0","RevenuesConverted_3_Q3_USD":"2700218000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"764984000.0","Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"223299000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"223157000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"223299000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"223157000.0","filed":"20171109","footnote":null,"form":"10-Q","fp":"Q3","fy":"2017.0","name":"ENDO INTERNATIONAL PLC","period":"20170930","qtrs":"0","uom":"USD"}]